5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.82▲ | 0.82▲ | 0.80▲ | 0.79▲ | 0.82▲ |
MA10 | 0.81▲ | 0.80▲ | 0.79▲ | 0.80▲ | 1.85▼ |
MA20 | 0.79▲ | 0.79▲ | 0.79▲ | 0.96▼ | 2.60▼ |
MA50 | 0.79▲ | 0.80▲ | 0.81▲ | 2.17▼ | 8.59▼ |
MA100 | 0.81▲ | 0.83▲ | 0.94▼ | 2.83▼ | 91.25▼ |
MA200 | 0.83▲ | 1.43▼ | 1.94▼ | 6.84▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.009▲ | 0.010▲ | 0.010▲ | 0.063▲ | 0.928▲ |
RSI | 72.135▲ | 68.330▲ | 64.848▲ | 26.977▼ | 25.898▼ |
STOCH | 82.656▲ | 91.253▲ | 91.253▲ | 33.021 | 1.655▼ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -45.783 | -96.235▼ |
CCI | 166.466▲ | 188.384▲ | 260.972▲ | 59.407 | -102.398▼ |
Monday, June 23, 2025 12:59 PM
Revelation Biosciences Inc. (REVB) stock has hit a 52-week low, trading at $2.71, as the company faces a challenging period marked ...
|
Thursday, May 29, 2025 07:56 PM
Revelation Biosciences, Inc. (NASDAQ:REVB), a clinical-stage life sciences company dedicated to rebalancing inflammation for improved health outcomes, has successfully closed a public offering, ...
|
Thursday, May 29, 2025 05:23 PM
Therefore, it is recommended to visit the company's website for up to date information. Nasdaq Insider Activity page provides trading information of corporate insiders (officers, directors and any ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
24/06/25 | 0.8231 | 0.855 | 0.8231 | 0.855 | 340,671 |
23/06/25 | 0.75 | 0.789 | 0.746 | 0.774 | 306,241 |
20/06/25 | 0.782 | 0.7864 | 0.7425 | 0.746 | 211,824 |
18/06/25 | 0.81 | 0.81 | 0.7803 | 0.7946 | 158,773 |
17/06/25 | 0.80 | 0.8123 | 0.76 | 0.79 | 378,114 |
16/06/25 | 0.7939 | 0.815 | 0.785 | 0.8022 | 235,310 |
13/06/25 | 0.794 | 0.8106 | 0.7803 | 0.794 | 315,542 |
12/06/25 | 0.8237 | 0.8355 | 0.78 | 0.805 | 394,362 |
11/06/25 | 0.83 | 0.85 | 0.81 | 0.8309 | 318,702 |
10/06/25 | 0.851 | 0.8677 | 0.84 | 0.84 | 264,157 |
|
|
||||
|
|
||||
|
|